Research projects
Start of main content
Epigenetic alterations in tetraploid neurones and Alzheimer's disease
16th national competition for scientific and technical research
The genome and epigenome
Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
Abstract
Objective 1: the establishment of a colony of Mapttm1(GFP)Klt/J mice in the animal facility of the Cajal Institute (months 1‑12).
During the first six months of the project a colony of Mapttm1(GFP)Klt/J mice was created in the animal facility of Cajal Institute, which now has two litters of these mice. These mice will be fundamental in the isolation of neurones, given that they were designed to express protein GFP in them.
Objective 2: the differentiating genomic analysis between diploid and tetraploid neurons (months 4‑12).
Optimisation has commenced on the procedure to separate diploid from tetraploid neurons, based on the brain tissue of adult mice (wild-type mice). The use of papain as the proteolytic agent aids the disassociation of cerebral cortex cells, which can be marked with DraQ5, a DNA marker that crosses the membrane and marks DNA in vivo. The aim is to use this method to isolate tetraploid neurons from Mapttm1(GFP)Klt/J mouse tissue that will then be used to analyse genetic expression using microarrays.
Objective 3: Analysis of the epigenetic mechanisms involved in the changes in genetic expression associated with neuronal tetraploidy (months 13‑36). This phase of the project has yet to start.
Objective 4: Analysis of the epigenetic mechanisms involved in the changes in genetic expression associated with AD (months 1‑36).
The expansion of APP/PS1 transgenic mice has commenced, which will be crossed with Mapttm1(GFP)Klt/J mice to obtain information on changes in genetic expression in the neurons of APP/PS1 mice.
- Activities related
- Projects related
- News related
- Publications related
-
30
Nov
2021
Conferencia online Misterios de la mente humana: el futuro del cerebro y las ciencias neuronales ONLINE www.fundacionareces.tv/directo, Tuesday, 30 November 2021, 19:00 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Synaptogenesis induced by PI3K in memory processes 2006 Senior Researcher : Ángel José Acebes Vindel Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
- Effect of mutations in the glucocerebrosidase-1 gene on iPS cell-derived neurons from Parkinson´s disease patients. Rescue of the phenotype and cell transplantation 2016 Senior Researcher : Carlos Vicario Abejón Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
- Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS) 2018 Senior Researcher : Antonio Artigas Raventós Research Centre or Institution : Instituto de Investigación e Innovación Parc Taulí (I3PT), Corporación Sanitaria i Universitaria Parc Taulí
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
End of main content